Differential Methylation of the HPV 16 upstream regulatory region during epithelial differentiation and neoplastic transformation

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Vinokurova, Svetlana ^a   von Knebel Doeberitz, Magnus ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; VIRUS DNA;

ARTICLE; BINDING SITE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL FRACTIONATION; CONTROLLED STUDY; DNA FLANKING REGION; DNA ISOLATION; DNA METHYLATION; DNA SEQUENCE; FEMALE; GENE INACTIVATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC LINKAGE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; MALIGNANT TRANSFORMATION; NONHUMAN; NUCLEOTIDE SEQUENCE; SYNDROME DELINEATION; TRANSCRIPTION REGULATION; VIRUS GENE; VIRUS GENOME; VIRUS REPLICATION; CELL TRANSFORMATION; GENETICS; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MICRODISSECTION; PHYSIOLOGY; REGULATORY SEQUENCE; UTERINE CERVIX CARCINOMA IN SITU; VIROLOGY;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; PAPILLOMAVIRIDAE;

CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA METHYLATION; DNA, VIRAL; HUMAN PAPILLOMAVIRUS 16; HUMANS; IMMUNOHISTOCHEMISTRY; MICRODISSECTION; REGULATORY SEQUENCES, NUCLEIC ACID;

EID: 80052531865     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024451     Document Type: Article

References (55)

1. zur Hausen H, (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2: 342-350.
2. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S, (2007) Human papillomavirus and cervical cancer. Lancet 370: 890-907.
3. Bodily J, Laimins LA, (2011) Persistence of human papillomavirus infection: keys to malignant progression. Trends Microbiol 19: 33-39.
4. zur Hausen H, (1986) Intracellular surveillance of persisting viral infections. Human genital cancer results from deficient cellular control of papillomavirus gene expression. Lancet 2: 489-491.
5. zur Hausen H, (2000) Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 92: 690-698.
6. Kines RC, Thompson CD, Lowy DR, Schiller JT, Day PM, (2009) The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding. Proc Natl Acad Sci U S A 106: 20458-20463.
7. Doorbar J, (2007) Papillomavirus life cycle organization and biomarker selection. Dis Markers 23: 297-313.
8. Middleton K, Peh W, Southern S, Griffin H, Sotlar K, et al. (2003) Organization of human papillomavirus productive cycle during neoplastic progression provides a basis for selection of diagnostic markers. J Virol 77: 10186-10201.
9. Wang HK, Duffy AA, Broker TR, Chow LT, (2009) Robust production and passaging of infectious HPV in squamous epithelium of primary human keratinocytes. Genes Dev 23: 181-194.
10. Durst M, Glitz D, Schneider A, zur Hausen H, (1992) Human papillomavirus type 16 (HPV 16) gene expression and DNA replication in cervical neoplasia: analysis by in situ hybridization. Virology 189: 132-140.
11. Stoler MH, Rhodes CR, Whitbeck A, Wolinsky SM, Chow LT, et al. (1992) Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. Hum Pathol 23: 117-128.
12. Klaes R, Friedrich T, Spitkovsky D, Ridder R, Rudy W, et al. (2001) Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 92: 276-284.
13. Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T, (1998) Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol 153: 1741-1748.
14. von Knebel Doeberitz M, (2002) New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections. Eur J Cancer 38: 2229-2242.
15. von Knebel Doeberitz M, Vinokurova S, (2009) Host factors in HPV-related carcinogenesis: cellular mechanisms controlling HPV infections. Arch Med Res 40: 435-442.
16. Thierry F, (2009) Transcriptional regulation of the papillomavirus oncogenes by cellular and viral transcription factors in cervical carcinoma. Virology 384: 375-379.
17. Arias-Pulido H, Peyton CL, Joste NE, Vargas H, Wheeler CM, (2006) Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer. J Clin Microbiol 44: 1755-1762.
18. Klaes R, Woerner SM, Ridder R, Wentzensen N, Duerst M, et al. (1999) Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res 59: 6132-6136.
19. Pett M, Coleman N, (2007) Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis? J Pathol 212: 356-367.
20. Vinokurova S, Wentzensen N, Kraus I, Klaes R, Driesch C, et al. (2008) Type-dependent integration frequency of human papillomavirus genomes in cervical lesions. Cancer Res 68: 307-313.
21. Melsheimer P, Vinokurova S, Wentzensen N, Bastert G, von Knebel Doeberitz M, (2004) DNA aneuploidy and integration of human papillomavirus type 16 e6/e7 oncogenes in intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix uteri. Clin Cancer Res 10: 3059-3063.
22. Feinberg AP, (2007) Phenotypic plasticity and the epigenetics of human disease. Nature 447: 433-440.
23. Gonzalo S, (2010) Epigenetic alterations in aging. J Appl Physiol 109: 586-597.
24. Ikegami K, Ohgane J, Tanaka S, Yagi S, Shiota K, (2009) Interplay between DNA methylation, histone modification and chromatin remodeling in stem cells and during development. Int J Dev Biol 53: 203-214.
25. Shiota K, (2004) DNA methylation profiles of CpG islands for cellular differentiation and development in mammals. Cytogenet Genome Res 105: 325-334.
26. Yamada Y, Watanabe A, (2010) Epigenetic codes in stem cells and cancer stem cells. Adv Genet 70: 177-199.
27. Kulis M, Esteller M, (2010) DNA methylation and cancer. Adv Genet 70: 27-56.
28. Taby R, Issa JP, (2010) Cancer epigenetics. CA Cancer J Clin 60: 376-392.
29. Badal S, Badal V, Calleja-Macias IE, Kalantari M, Chuang LS, et al. (2004) The human papillomavirus-18 genome is efficiently targeted by cellular DNA methylation. Virology 324: 483-492.
30. Badal V, Chuang LS, Tan EH, Badal S, Villa LL, et al. (2003) CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression. J Virol 77: 6227v6234.
31. Balderas-Loaeza A, naya-Saavedra G, Ramirez-Amador VA, Guido-Jimenez MC, Kalantari M, et al. (2007) Human papillomavirus-16 DNA methylation patterns support a causal association of the virus with oral squamous cell carcinomas. Int J Cancer 120: 2165-2169.
32. Bhattacharjee B, Sengupta S, (2006) CpG methylation of HPV 16 LCR at E2 binding site proximal to P97 is associated with cervical cancer in presence of intact E2. Virology 354: 280-285.
33. Brandsma JL, Sun Y, Lizardi PM, Tuck DP, Zelterman D, et al. (2009) Distinct human papillomavirus type 16 methylomes in cervical cells at different stages of premalignancy. Virology 389: 100-107.
34. Ding DC, Chiang MH, Lai HC, Hsiung CA, Hsieh CY, et al. (2009) Methylation of the long control region of HPV16 is related to the severity of cervical neoplasia. Eur J Obstet Gynecol Reprod Biol 147: 215-220.
35. Fernandez AF, Rosales C, Lopez-Nieva P, Grana O, Ballestar E, et al. (2009) The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer. Genome Res 19: 438-451.
36. Hublarova P, Hrstka R, Rotterova P, Rotter L, Coupkova M, et al. (2009) Prediction of human papillomavirus 16 e6 gene expression and cervical intraepithelial neoplasia progression by methylation status. Int J Gynecol Cancer 19: 321-325.
37. Kalantari M, Calleja-Macias IE, Tewari D, Hagmar B, Lie K, et al. (2004) Conserved methylation patterns of human papillomavirus type 16 DNA in asymptomatic infection and cervical neoplasia. J Virol 78: 12762-12772.
38. Kalantari M, Villa LL, Calleja-Macias IE, Bernard HU, (2008) Human papillomavirus-16 and-18 in penile carcinomas: DNA methylation, chromosomal recombination and genomic variation. Int J Cancer 123: 1832-1840.
39. Kalantari M, Garcia-Carranca A, Morales-Vazquez CD, Zuna R, Montiel DP, et al. (2009) Laser capture microdissection of cervical human papillomavirus infections: copy number of the virus in cancerous and normal tissue and heterogeneous DNA methylation. Virology 390: 261-267.
40. Sun C, Reimers LL, Burk RD, (2011) Methylation of HPV16 genome CpG sites is associated with cervix precancer and cancer. Gynecol Oncol.
41. Kalantari M, Lee D, Calleja-Macias IE, Lambert PF, Bernard HU, (2008) Effects of cellular differentiation, chromosomal integration and 5-aza-2′-deoxycytidine treatment on human papillomavirus-16 DNA methylation in cultured cell lines. Virology 374: 292-303.
42. Kim K, Garner-Hamrick PA, Fisher C, Lee D, Lambert PF, (2003) Methylation patterns of papillomavirus DNA, its influence on E2 function, and implications in viral infection. J Virol 77: 12450-12459.
43. Thain A, Jenkins O, Clarke AR, Gaston K, (1996) CpG methylation directly inhibits binding of the human papillomavirus type 16 E2 protein to specific DNA sequences. J Virol 70: 7233-7235.
44. Huang MZ, Li HB, Nie XM, Wu XY, Jiang XM, (2010) An analysis on the combination expression of HPV L1 capsid protein and p16INK4a in cervical lesions. Diagn Cytopathol 38: 573-578.
45. Yoshida T, Sano T, Kanuma T, Owada N, Sakurai S, et al. (2008) Immunochemical analysis of HPV L1 capsid protein and p16 protein in liquid-based cytology samples from uterine cervical lesions. Cancer 114: 83-88.
46. Xiong Z, Laird PW, (1997) COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res 25: 2532-2534.
47. Piyathilake CJ, Macaluso M, Alvarez RD, Chen M, Badiga S, et al. (2010) A higher degree of methylation of the HPV 16 E6 gene is associated with a lower likelihood of being diagnosed with cervical intraepithelial neoplasia. Cancer.
48. Turan T, Kalantari M, Calleja-Macias IE, Cubie HA, Cuschieri K, et al. (2006) Methylation of the human papillomavirus-18 L1 gene: a biomarker of neoplastic progression? Virology 349: 175-183.
49. Turan T, Kalantari M, Cuschieri K, Cubie HA, Skomedal H, et al. (2007) High-throughput detection of human papillomavirus-18 L1 gene methylation, a candidate biomarker for the progression of cervical neoplasia. Virology 361: 185-193.
50. Doerfler W, (2006) De novo methylation, long-term promoter silencing, methylation patterns in the human genome, and consequences of foreign DNA insertion. Curr Top Microbiol Immunol 301: 125-175.
51. Van Tine BA, Kappes JC, Banerjee NS, Knops J, Lai L, et al. (2004) Clonal selection for transcriptionally active viral oncogenes during progression to cancer. J Virol 78: 11172-11186.
52. Dong G, Broker TR, Chow LT, (1994) Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements. J Virol 68: 1115-1127.
53. Rapp B, Pawellek A, Kraetzer F, Schaefer M, May C, et al. (1997) Cell-type-specific separate regulation of the E6 and E7 promoters of human papillomavirus type 6a by the viral transcription factor E2. J Virol 71: 6956-6966.
54. Steger G, Corbach S, (1997) Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein. J Virol 71: 50-58.
55. Rishi V, Bhattacharya P, Chatterjee R, Rozenberg J, Zhao J, et al. (2010) CpG methylation of half-CRE sequences creates C/EBPalpha binding sites that activate some tissue-specific genes. Proc Natl Acad Sci U S A 107: 20311-20316.